In Brief This Week: Sequenom; Beckman Coulter; Expression Analysis; Crown Bioscience, Horizon Discovery; DiagnoCure; Pall; Pressure BioSciences | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom said in its Form 10-K filed with the US Securities and Exchange Commission this week that the US Patent and Trademark Office on March 12 declared a patent interference between US Patent No. 8,008,018 held by Verinata Health, now part of Illumina, and Sequenom's pending patent application No. 13/070,275. In February 2012, Verinata and Stanford University sued Sequenom alleging it infringes the patent through the offering of its MaterniT21 Plus test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

Dec
13
Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Dec
15
Sponsored by
PierianDx

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.